BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 28779028)

  • 21. Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment.
    Cox R; Phillips O; Fukumoto J; Fukumoto I; Parthasarathy PT; Arias S; Cho Y; Lockey RF; Kolliputi N
    Am J Respir Cell Mol Biol; 2015 Sep; 53(3):422-35. PubMed ID: 25647402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Annexin A1/FPR2 pathway controls the inflammatory response and bacterial dissemination in experimental pneumococcal pneumonia.
    Machado MG; Tavares LP; Souza GVS; Queiroz-Junior CM; Ascenção FR; Lopes ME; Garcia CC; Menezes GB; Perretti M; Russo RC; Teixeira MM; Sousa LP
    FASEB J; 2020 Feb; 34(2):2749-2764. PubMed ID: 31908042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation.
    Nunes VS; Abrahão O; Rogério AP; Serhan CN
    J Phys Chem B; 2023 Jul; 127(29):6479-6486. PubMed ID: 37428488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
    Kang JW; Lee SM
    Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms.
    Filiberto AC; Ladd Z; Leroy V; Su G; Elder CT; Pruitt EY; Hensley SE; Lu G; Hartman JB; Zarrinpar A; Sharma AK; Upchurch GR
    FASEB J; 2022 Nov; 36(11):e22579. PubMed ID: 36183323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of aspirin-triggered resolvin D1 on spinal nociceptive processing in rat pain models.
    Meesawatsom P; Burston J; Hathway G; Bennett A; Chapman V
    J Neuroinflammation; 2016 Sep; 13(1):233. PubMed ID: 27589850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions.
    Norling LV; Dalli J; Flower RJ; Serhan CN; Perretti M
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1970-8. PubMed ID: 22499990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual role of lipoxin A4 in pneumosepsis pathogenesis.
    Sordi R; Menezes-de-Lima O; Horewicz V; Scheschowitsch K; Santos LF; Assreuy J
    Int Immunopharmacol; 2013 Oct; 17(2):283-92. PubMed ID: 23816538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RvD1 ameliorates LPS-induced acute lung injury via the suppression of neutrophil infiltration by reducing CXCL2 expression and release from resident alveolar macrophages.
    Zhang HW; Wang Q; Mei HX; Zheng SX; Ali AM; Wu QX; Ye Y; Xu HR; Xiang SY; Jin SW
    Int Immunopharmacol; 2019 Nov; 76():105877. PubMed ID: 31522017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-β regulates proresolving lipids to promote the resolution of acute airway inflammation.
    Sekheri M; Rizo-Téllez SA; Othman A; El Kebir D; Filep JG
    Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2201146119. PubMed ID: 35878041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolution of post-lung transplant ischemia-reperfusion injury is modulated via Resolvin D1-FPR2 and Maresin 1-LGR6 signaling.
    Leroy V; Cai J; Tu Z; McQuiston A; Sharma S; Emtiazjoo A; Atkinson C; Upchurch GR; Sharma AK
    J Heart Lung Transplant; 2023 May; 42(5):562-574. PubMed ID: 36628837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AT-RvD1 modulates the activation of bronchial epithelial cells induced by lipopolysaccharide and Dermatophagoides pteronyssinus.
    de Oliveira JR; da Silva PR; Rogério AP
    Eur J Pharmacol; 2017 Jun; 805():46-50. PubMed ID: 28322829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 15-epi-Lipoxin A
    Sham HP; Walker KH; Abdulnour RE; Krishnamoorthy N; Douda DN; Norris PC; Barkas I; Benito-Figueroa S; Colby JK; Serhan CN; Levy BD
    J Immunol; 2018 Apr; 200(8):2757-2766. PubMed ID: 29523657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease.
    Carrillo I; Rabelo RAN; Barbosa C; Rates M; Fuentes-Retamal S; González-Herrera F; Guzmán-Rivera D; Quintero H; Kemmerling U; Castillo C; Machado FS; Díaz-Araya G; Maya JD
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009978. PubMed ID: 34784372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hierarchical effects of pro-inflammatory cytokines on the post-influenza susceptibility to pneumococcal coinfection.
    Duvigneau S; Sharma-Chawla N; Boianelli A; Stegemann-Koniszewski S; Nguyen VK; Bruder D; Hernandez-Vargas EA
    Sci Rep; 2016 Nov; 6():37045. PubMed ID: 27872472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G-CSFR antagonism reduces neutrophilic inflammation during pneumococcal and influenza respiratory infections without compromising clearance.
    Wang H; Aloe C; Wilson N; Bozinovski S
    Sci Rep; 2019 Nov; 9(1):17732. PubMed ID: 31776393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
    Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
    Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
    J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease.
    Bozinovski S; Uddin M; Vlahos R; Thompson M; McQualter JL; Merritt AS; Wark PA; Hutchinson A; Irving LB; Levy BD; Anderson GP
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):935-40. PubMed ID: 22215599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.